BIO Announces Presenters for Annual Convention - - BioPharm International

ADVERTISEMENT

BIO Announces Presenters for Annual Convention


The Biotechnology Industry Organization (BIO) announced the companies confirmed to present at the 2013 BIO International Convention in sessions designed to increase visibility, attract more partners, and pitch their business objectives to a global audience.

The BIO International Convention, scheduled for April 22-25 at McCormick Place in Chicago, will highlight the trends and opportunities for executives, investors, scientists, policy leaders, and media in medicine, diagnostics, the environment, energy production, business operations, financing, partnerships, policy issues, and food and agriculture. The event is hosted by the Biotechnology Industry Organization (BIO).

The BIO Business Forum will host partnering meetings, workshops and a full program of sessions geared toward life science executives. The Business Development educational track will feature education programming discussing partnering, emerging markets, big pharma, and deal making.

“Now in its twelfth year, the industry’s largest partnering event is looking to host a record breaking 25,000+ partnering meetings this year via the One-on-One Partnering System in the BIO Business Forum and BIO Exhibition,” said BIO’s CEO and President Jim Greenwood. “The One-on-One Partnering System facilitates an unparalleled opportunity for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather in one place, meet one-on-one, and discuss business opportunities.”

Other events include Exhibitor Booth Partnering, which allows qualified exhibitors to schedule meetings in their personal exhibitor booths; and the Rare Disease Partnering Summit, which features presentations from pediatric research institutions. Five of these pediatric institutions will present their translational research projects and partnering opportunities focused on rare diseases, April 24 from 2 – 5 p.m.

 

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
Author Guidelines

Click here